Osborne Clarke has advised RHYTHM AI, a UK company focused on the treatment of Atrial Fibrillation, on the closure of a £2.15m seed financing round. AF…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now